Alpha 2.0
Login Register
» Articles » PMID: 28314906

Association of Benign Prostatic Hyperplasia (BPH) Volume and Prostate Cancer: Consecutive Data from an Academic Institution in Respect to the Current Scientific View

Overview
Journal World J Urol
Specialty Urology
Date 2017 Mar 19
PMID 28314906
Citations 1
Authors
Shadi Khalil
Werner de Riese
Affiliations
Soon will be listed here.
Citing Articles

ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.

Tan G, Jiang L, Li G, Bai K Technol Cancer Res Treat. 2020; 19:1533033820948062.

PMID: 33063634 PMC: 7580129. DOI: 10.1177/1533033820948062.

References
1.
Marks L, Roehrborn C, Wolford E, Wilson T . The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response. J Urol. 2007; 177(4):1408-13. DOI: 10.1016/j.juro.2006.11.095. View
2.
Boehm K, Valdivieso R, Meskawi M, Larcher A, Sun M, Sosa J . BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS). World J Urol. 2015; 33(12):2063-9. DOI: 10.1007/s00345-015-1546-z. View
3.
Al-Khalil S, Boothe D, Durdin T, Sunkara S, Watkins P, Yang S . Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review. Int Urol Nephrol. 2015; 48(1):91-7. DOI: 10.1007/s11255-015-1146-2. View
4.
Ung J, San Francisco I, Regan M, DeWolf W, Olumi A . The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol. 2002; 169(1):130-5. DOI: 10.1016/S0022-5347(05)64052-9. View
5.
Werahera P, Sullivan K, La Rosa F, Kim F, Lucia M, ODonnell C . Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume. Int J Clin Exp Pathol. 2012; 5(9):892-9. PMC: 3484481. View